Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:clinical_trial
|
| gptkbp:clinicalTrials.gov_Identifier |
NCT02224755
|
| gptkbp:conditionStudied |
advanced heart failure
|
| gptkbp:designer |
randomized
multicenter open-label |
| gptkbp:endDate |
2016
|
| gptkbp:enrollment |
1028
|
| gptkbp:foundIn |
HeartMate 3 was superior to HeartMate II for survival free of disabling stroke or reoperation at 2 years
Lower rates of pump thrombosis with HeartMate 3 Lower rates of stroke with HeartMate 3 |
| gptkbp:fullName |
Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3
|
| https://www.w3.org/2000/01/rdf-schema#label |
MOMENTUM 3 trial
|
| gptkbp:location |
gptkb:United_States
|
| gptkbp:period |
Phase III
|
| gptkbp:principalInvestigator |
Mandeep R. Mehra
|
| gptkbp:publishedIn |
N Engl J Med. 2017;377(7):633-644
|
| gptkbp:result |
survival free of disabling stroke or reoperation to replace or remove a malfunctioning device
|
| gptkbp:sponsor |
gptkb:Abbott_Laboratories
|
| gptkbp:startDate |
2014
|
| gptkbp:studiedDevice |
HeartMate 3 LVAD
HeartMate II LVAD |
| gptkbp:bfsParent |
gptkb:HeartMate_3
|
| gptkbp:bfsLayer |
7
|